AIDX — Healwell Al Income Statement
0.000.00%
Last trade - 00:00
- CA$215.99m
- CA$227.73m
- CA$7.32m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46.3 | 38.6 | 47.8 | 10.4 | 7.32 |
Cost of Revenue | |||||
Gross Profit | 15.3 | 12.9 | 15 | 3.71 | 1.26 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 48.7 | 41.9 | 64.3 | 27.7 | 37.2 |
Operating Profit | -2.36 | -3.29 | -16.4 | -17.3 | -29.9 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.029 | -1.34 | -16.3 | -17.1 | -32.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.121 | -1.03 | -15.5 | -18.2 | -32.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.12 | -1.03 | -15.7 | -21.1 | -31.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.12 | -1.03 | -15.7 | -21.1 | -31.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.001 | -0.34 | -0.368 | -0.415 |
Dividends per Share |